قائمة أكبر شركات الطب الحيوي حسب الدخل
القائمة التالية لأكبر شركات الأدوية، التكنولوجيا الحيوية والطب المستقلة مرتبة حسب الدخل (10 بليون دولار) تبعاً للسنة المالية، ولا تتضمن شركات التكنولوجيا الحيوية المملوكة أو التي تعتبر جزء مجموعات الأدوية الكبرى.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
أكبر شركات الأدوية العالمية بدخل أكبر من 10 بليون
| ترتيب | شعار | الشركة | 2019 بليون$ |
2018 بليون$ |
2017 بليون$ |
2016 بليون$ |
2015 بليون$ |
2014 بليون$ |
2013 بليون$ |
2012 بليون$ |
2011 بليون$ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1 |  |
 جونسون أند جونسونNYSE: JNJ |
82.06[1] | 81.60[2] | 76.50[3] | 71.89[4] | 70.10[5] | 74.30[6] | 71.31[7] | 67.20[8] | 65.00[9] |
|
2 | |
 روشSIX: ROG |
63.85[10] | 56.86[11] | 57.37[12] | 50.11[13] | 47.70[14] | 49.86[15] | 48.53[16] | 47.80[17] | 45.21[18] |
|
3 | |
فايزر NYSE: PFE |
51.75[19] | 53.60[20] | 52.54[21] | 52.82[22] | 48.85[23] | 49.61[24] | 51.58[25] | 58.99[26] | 65.26[27] |
|
4 | |
نوڤارتس NYSE: NVS |
47.45[28] | 44.75[29] | 49.11[30] | 48.52[31] | 49.41[32] | 58.00[33] | 57.36[34] | 56.67[35] | 58.57[36] |
|
5 | ▲ 4 |  بايرFWB: BAYN |
38.24 Q3[37] | 45.06[38] | 37.94[39] | 25.27[40] | 24.09[41] | 25.47[42] | 24.17[43] | 24.30[44] | 23.11[45] |
|
6 | |
 گلاكسو سميث كلاينLSE: GSK |
32.22 Q3[46] | 43.14[47] | 42.05[48] | 34.79[49] | 29.84[50] | 37.96[51] | 41.61[52] | 39.93[53] | 41.39[54] |
|
7 | |
مرك NYSE: MRK |
34.98 Q3[55] | 42.30[56] | 40.10[57] | 39.80[58] | 39.50[59] | 42.24[60] | 44.03[61] | 47.27[62] | 48.05[63] |
|
8 |  3 |
 سانوفيNYSE: SNY |
29.57 Q3[64] | 39.07[65] | 42.91[66] | 36.57[67] | 36.73[68] | 43.07[69] | 42.08[70] | 46.41[71] | 44.34[72] |
|
9 | ▲ 1 | آبڤي NYSE: ABBV |
24.56 Q3[73] | 32.75[74] | 28.22[75] | 25.56[76] | 22.82[77] | 19.96[78] | 18.79[79] | – | – |
|
10 | |
معامل أبوت NASDAQ: ABT |
31.90[80] | 30.60[81] | 27.39[82] | 20.85[83] | 20.41[84] | 20.25[85] | 21.85[86] | 39.87[87] | 38.85[88] |
|
11 | |
ثرمو فيشر ساينتفيك NYSE: TMO |
25.54[89] | 24.36[90] | 20.92[91] | 18.27[92] | 16.97[93] | 16.89[94] | 13.09[95] | 12.51[96] | 11.56[97] |
|
11 | ▲ 1 | إلاي لـِلي NYSE: LLY |
22.32[98] | 21.49[99] | 22.90[100] | 21.22[101] | 20.00[102] | 19.62[103] | 23.11[104] | 22.60[105] | 24.29[106] |
|
12 | ▲ 1 | أمجين NASDAQ: AMGN |
23.40[107] | 23.70[108] | 22.80[109] | 22.99[110] | 21.66[111] | 20.06[112] | 18.68[113] | 17.30[114] | 15.58[115] |
|
13 | ▲ 4 | بريستول-مايرز سكويب NASDAQ: BMY |
18.32 Q3[116] | 22.56[117] | 20.80[118] | 19.43[119] | 16.56[120] | 15.88[121] | 16.39[122] | 17.62[123] | 21.24[124] |
|
14 | 3 |
گلعاد للعلوم NASDAQ: GILD |
16.32 Q3[125] | 22.13[126] | 25.70[127] | 30.39[127] | 32.15[127] | 24.47[127] | 10.80[127] | 9.70[127] | 8.39[127] |
|
15 | 1 |
أسترازنكا LSE: AZN |
17.72 Q3[128] | 22.09[129] | 22.47[130] | 23.00[131] | 24.71[132] | 26.10[133] | 25.71[134] | 27.97[135] | 33.59[136] |
|
16 | 1 |
 / تـِڤا للصناعات الدوائيةNASDAQ: TEVA |
4.30 Q1[137] | 18.90[138] | 22.40[139] | 21.90[140] | 20.00[141] | 20.27[142] | 20.31[143] | 18.31[144] | 16.12[145] |
|
17 | |
بورنگر إنگلهايم خاصة |
19.48[146] | 21.67[147] | 17.54[148] | 16.41[148] | 17.70[148] | 18.68[148] | 18.89[148] | 18.34[148] | |
|
18 | |
 تاكيدا للأدويةTYO: 4502[N 1] |
19.10[149] | 16.70[150] | 15.96 | 14.93 | 16.84 | 17.36 | 18.91 | 17.80 | |
|
19 | |
مجموعة مرك ETR: MRK |
8.66 Q2[151] | 16.48[152] | 18.70[153] | 16.62[154] | 14.25[155] | 15.29[156] | 14.73[153] | 14.36[153] | 14.31[153] |
|
20 | |
 نوڤو نورديسكNYSE: NVO |
13.39 Q3[157] | 16.99[158] | 18.77[159] | 16.61[160] | 16.06[161] | 15.83[162] | 14.88[163] | 13.48[164] | 11.56[165] |
|
21 | |
 ألرگانNYSE: AGN |
7.69 Q2[166] | 15.78[167] | 15.94[168] | 14.57[168] | 15.07[168] | 12.88[169] | 8.68[170] | 5.91[171] | 4.58[172] |
|
22 | |
داناهر كورپوريشن NYSE: DHR |
15.07 Q3[173] | 19.89[174] | 18.33[175] | 16.88[176] | 20.56[177] | 19.91[178] | 19.12[179] | 18.26[180] | 16.09[181] |
|
23 | |
سلجين NASDAQ: CELG |
12.95 Q3[182] | 15.28[183] | 13.00 | 11.23 | 9.26 | 7.67 | 6.49 | 5.51 | 4.84 |
|
24 | |
بيوجين NASDAQ: BIIB |
10.71 Q3[184] | 13.45[185] | 12.30[186] | 11.40[187] | 10.80[188] | 9.70[189] | 6.90[190] | 5.50[191] | 5.00[192] |
|
25 | |
أستلاس فارما TYO: 4503 |
12.27[193] | 12.07 | 12.63 | 11.48 | 10.49 | 9.25 | 8.92 | 8.78 | |
|
26 | |
لابكورپ NYSE: LH |
8.60 Q3[194] | 11.33[195] | 10.31[195] | 9.55[195] | 8.51[195] | 6.01[195] | 5.81[196] | 5.67[196] | 5.54[196] |
|
27 | |
باكستر إنترناشونال NYSE: BAX |
8.28 Q3[197] | 11.13 [198] | 10.56 [198] | 10.16 [199] | 9.97 [200] | 10.72 [201] | 14.97 [202] | 14.19 [203] | 13.89 [203] |
|
28 | |
مايلان NASDAQ: MYL |
5.35 Q2[204] | 11.43 [205] | 11.91 [205] | 11.08 [205] | 9.43 [205] | 7.72 [205] | 6.91 [206] | 6.80 [206] | 6.13 [206] |
انظر أيضاً
الهوامش
المصادر
- ^ https://www.biospace.com/article/releases/johnson-and-amp-johnson-reports-2019-fourth-quarter-and-full-year-results-/?s=72
- ^ "Johnson & Johnson Reports 2018 Fourth-Quarter Results:". Content Lab - U.S.
- ^ "Johnson & Johnson Reports 2017 Fourth-Quarter Results: - Johnson & Johnson". www.jnj.com.
- ^ "Johnson & Johnson Reports 2016 Fourth-Quarter Results - Johnson & Johnson". www.jnj.com.
- ^ "Johnson & Johnson Reports 2015 Fourth-Quarter Results:".
- ^ "Johnson & Johnson Reports 2014 Fourth-Quarter and Full-Year Results - Johnson & Johnson". www.jnj.com.
- ^ "Johnson & Johnson Reports 2013 Fourth-Quarter and Full-Year Results - Johnson & Johnson". www.jnj.com.
- ^ "Johnson & Johnson Reports 2012 Fourth-Quarter and Full-Year Results:".
- ^ "Johnson & Johnson Reports 2011 Fourth-Quarter and Full-Year Results:".
- ^ https://www.roche.com/dam/jcr:e49f6995-e813-43c1-9302-c9b7d0bddbc8/en/irp200130-a.pdf
- ^ https://www.roche.com/dam/jcr:af865dfd-50fb-458b-9cac-34097db9d3ec/en/ar18e.pdf
- ^ "Roche reports good results in 2017". www.roche.com.
- ^ https://www.roche.com/dam/jcr:ee2f197f-5487-4629-9e28-66b77c9cbbab/en/ar16e.pdf
- ^ https://www.roche.com/dam/jcr:9b36e11d-495c-42f5-b757-e80c4e88d793/en/gb15e.pdf
- ^ https://www.roche.com/dam/jcr:880b44a1-3fd6-4e66-bf10-f4af1e724d4d/en/gb14e.pdf
- ^ https://www.roche.com/dam/jcr:64fd6b2d-1a76-467f-badd-ab94b85b6d70/en/gb13e.pdf
- ^ https://www.roche.com/dam/jcr:3e048249-e3ce-4969-a77e-cc90d8f3fa73/en/gb12e.pdf
- ^ https://www.roche.com/dam/jcr:52174b39-feab-4210-82f6-9b8786a69ecf/en/gb11e.pdf
- ^ https://www.biospace.com/article/releases/pfizer-reports-fourth-quarter-and-full-year-2019-results/?s=72
- ^ https://s21.q4cdn.com/317678438/files/doc_financials/Quarterly/2018/q4/Q4-2018-PFE-Earnings-Release.pdf
- ^ https://s21.q4cdn.com/317678438/files/doc_financials/Quarterly/2017/Q4_2017_PFE_Earnings_Release.pdf
- ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2016/2016-financial-report.pdf
- ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2015/2015_Pfizer_Financial_Report.pdf
- ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2014/2014_Pfizer_Financial_Report.pdf
- ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2013/FinancialReport2013.pdf
- ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2012/financial2012.pdf
- ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2011/financial2011.pdf
- ^ https://www.novartis.com/sites/www.novartis.com/files/q4-2019-media-release-en.pdf
- ^ https://www.novartis.com/sites/www.novartis.com/files/q4-2018-media-release-en.pdf
- ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2017-en.pdf
- ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2016-en.pdf
- ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2015-en.pdf
- ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2014-en.pdf
- ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2013-en.pdf
- ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2012-en.pdf
- ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2011-en.pdf
- ^ https://www.bayer.com/en/quarterly-reports.aspx
- ^ "Bayer's Annual Report 2018". www.annualreport2018.bayer.com.
- ^ http://www.annualreport2017.bayer.com/servicepages/downloads/files/bayer_ar17_entire.pdf
- ^ http://www.annualreport2016.bayer.com/servicepages/downloads/files/bayer_ar16_entire.pdf
- ^ http://www.annualreport2015.bayer.com/servicepages/downloads/files/entire_bayer_ar15.pdf
- ^ AG, Bayer. "Bayer – Global Home". www.bayer.com.
- ^ https://www.bayer.com/en/ar-2013.pdfx
- ^ https://www.bayer.com/en/ar-2012.pdfx
- ^ https://www.bayer.com/en/ar-2011.pdfx
- ^ https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-sales-of-94-billion-plus16-aer-plus11-cer-pro-forma-plus6-cerstar/
- ^ "GSK delivers sales, earnings and cash flow growth in 2018 - GSK". www.gsk.com.
- ^ https://www.gsk.com/media/4629/fy-2017-results-announcement.pdf
- ^ https://www.gsk.com/media/3609/annual-report-2016.pdf
- ^ https://www.gsk.com/media/2718/gsk-annual-report-2016.pdf
- ^ https://www.gsk.com/media/2710/gsk-annual-report-2014-interactive.pdf
- ^ https://www.gsk.com/media/2701/annual-report-2013-interactive.pdf
- ^ https://www.gsk.com/media/2694/annual-report-2012.pdf
- ^ https://www.gsk.com/media/2696/annual-report-2011.pdf
- ^ https://www.biospace.com/article/releases/merck-announces-third-quarter-2019-financial-results/?s=72
- ^ "Merck Announces Fourth-Quarter and Full-Year 2018 Financial Results". BioSpace.
- ^ LaVito, Angelica (2 February 2018). "Merck posts mixed fourth-quarter results as Keytruda sales skyrocket".
- ^ http://s21.q4cdn.com/488056881/files/doc_financials/2017/Q4/merck-q4-10k.pdf
- ^ http://s21.q4cdn.com/488056881/files/doc_financials/2015/annual/MRK_2015_Form_10-K_FINAL_r879.pdf
- ^ http://s21.q4cdn.com/488056881/files/doc_financials/2014/annual/2014-Form-10-K_FINAL_022715.pdf
- ^ http://s21.q4cdn.com/488056881/files/doc_financials/2013/annual/MRK_2013_Form_10_K_FINAL_022714.pdf
- ^ http://s21.q4cdn.com/488056881/files/doc_financials/2012/annual/MRK_form_10_k_2012.pdf
- ^ http://s21.q4cdn.com/488056881/files/doc_financials/2011/annual/form-10-k-2011.pdf
- ^ https://www.sanofi.com/-/media/Project/One-Sanofi-Web/Websites/Global/Sanofi-COM/Home/en/investors/docs/Q3_2019_Results_Press_Release_EN.pdf?la=en&hash=8BF184008D241B7AB03515AE9F73CEB3
- ^ https://www.sanofi.com/-/media/Project/One-Sanofi-Web/Websites/Global/Sanofi-COM/Home/en/investors/docs/press-releases/Q42018results.pdf?la=en&hash=CDCE30350F0C658C000A909535AD9AF636A93560
- ^ https://www.sanofi.com/media/Project/One-Sanofi-Web/sanofi-com/en/investors/docs/press-releases/Press_release_Q4_FY_2017.pdf
- ^ https://en.sanofi.com/Images/49288_20-F_2016.pdf
- ^ https://en.sanofi.com/Images/45889_Sanofi_20-F_2015_V2.pdf
- ^ https://en.sanofi.com/Images/38473_Sanofi_20-F_2014.pdf
- ^ https://en.sanofi.com/Images/35795_20F_SANOFI_2013.pdf
- ^ https://en.sanofi.com/Images/31972_20-F_2012_V2.pdf
- ^ https://en.sanofi.com/Images/29804_20F_2011.pdf
- ^ https://investors.abbvie.com/news-releases/news-release-details/abbvie-reports-third-quarter-2019-financial-results
- ^ "AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results - AbbVie News Center". news.abbvie.com.
- ^ "Financial Release - AbbVie". investors.abbvie.com.
- ^ "Financial Release - AbbVie". investors.abbvie.com.
- ^ "Financial Release - AbbVie". investors.abbvie.com.
- ^ "Financial Release - AbbVie". investors.abbvie.com.
- ^ "Financial Release - AbbVie". investors.abbvie.com.
- ^ https://www.biospace.com/article/releases/abbott-reports-fourth-quarter-2019-results-announces-strong-forecast-for-2020/?s=72
- ^ "Abbott Reports 2018 Results and Issues Strong Forecast for 2019". BioSpace.
- ^ Abbott. "Abbott Reports Fourth-Quarter 2017 Results". www.prnewswire.com.
- ^ Abbott. "Abbott Reports Fourth-Quarter 2016 Results". www.prnewswire.com.
- ^ "Abbott Reports Fourth-Quarter 2015 Results".
- ^ "Abbott Reports Fourth-Quarter 2014 Results".
- ^ Abbott. "Abbott Reports Fourth-Quarter and Full-Year 2013 Results". www.prnewswire.com.
- ^ "Abbott Reports Fourth-Quarter and Full-Year 2012 Results".
- ^ "Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2011 Earnings - FiercePharma". www.fiercepharma.com.
- ^ https://www.biospace.com/article/releases/thermo-fisher-scientific-reports-fourth-quarter-and-full-year-2019-results/?s=72
- ^ https://www.biospace.com/article/releases/thermo-fisher-scientific-reports-fourth-quarter-and-full-year-2019-results/?s=72
- ^ https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2018/Thermo-Fisher-Scientific-Reports-Fourth-Quarter-and-Full-Year-2017-Results/default.aspx
- ^ https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2017/Thermo-Fisher-Scientific-Reports-Fourth-Quarter-and-Full-Year-2016-Results/default.aspx
- ^ https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2016/Thermo-Fisher-Scientific-Reports-Record-Fourth-Quarter-and-Full-Year-2015-Results/default.aspx
- ^ https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2015/Thermo-Fisher-Scientific-Reports-Strong-Fourth-Quarter-and-Full-Year-2014-Results/default.aspx
- ^ https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2015/Thermo-Fisher-Scientific-Reports-Strong-Fourth-Quarter-and-Full-Year-2014-Results/default.aspx
- ^ http://thermofisher.mediaroom.com/2013-01-31-Thermo-Fisher-Scientific-Reports-Fourth-Quarter-and-Full-Year-2012-Results
- ^ http://thermofisher.mediaroom.com/2013-01-31-Thermo-Fisher-Scientific-Reports-Fourth-Quarter-and-Full-Year-2012-Results
- ^ https://www.biospace.com/article/releases/lilly-reports-strong-fourth-quarter-and-full-year-2019-financial-results-updates-2020-guidance-for-pending-dermira-acquisition/?s=72
- ^ "Lilly Reports Strong Fourth-Quarter and Full-Year 2018 Financial Results, Lowers 2019 EPS Guidance to Reflect the Pending Acquisition of Loxo Oncology". BioSpace.
- ^ http://files.shareholder.com/downloads/LLY/5951368162x0x970018/15B962F7-AF5A-4FFA-BE13-42206D3A0820/Q4_2017_PressRelease.pdf
- ^ "Lilly Reports Fourth-Quarter and Full-Year 2016 Results (NYSE:LLY)". investor.lilly.com.
- ^ http://files.shareholder.com/downloads/LLY/5951368162x0x871993/5BE670A3-2B82-4876-8471-CA6BC3BD49F8/Lilly_Q4_2015_Press_Release.pdf
- ^ http://files.shareholder.com/downloads/LLY/5951368162x0x806120/8637C572-31C4-402E-A179-5E107A5366B2/Q414_Lilly_Sales_and_Earnings_Press_Release.pdf
- ^ http://files.shareholder.com/downloads/LLY/5951368162x0x721860/2DB60538-94FE-4E96-98D2-DA72CC301EA0/Q413%20Lilly%20Sales%20and%20Earnings%20Press%20Release.pdf
- ^ http://files.shareholder.com/downloads/LLY/5951368162x0x631117/85679233-E13C-4FE7-9431-E97EFFDA6D5D/Q412%20Lilly%20Sales%20and%20Earnings%20Press%20Release.pdf
- ^ http://files.shareholder.com/downloads/LLY/5951368162x0x538046/24A15621-7850-45EC-8E20-30535C3D9FC9/Q411_Lilly_Sales_and_Earnings_Press_Release.pdf
- ^ https://www.biospace.com/article/releases/amgen-reports-fourth-quarter-and-full-year-2019-financial-results/?s=72
- ^ "Amgen - Investors - Press Release". investors.amgen.com.
- ^ "Amgen Reports Fourth Quarter And Full Year 2017 Financial Results". www.amgen.com.
- ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjY1NTQ1fENoaWxkSUQ9MzczMzk1fFR5cGU9MQ==&t=1
- ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjI2OTYzfENoaWxkSUQ9MzI5ODc3fFR5cGU9MQ==&t=1
- ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTc0NTMzfENoaWxkSUQ9Mjc3NjczfFR5cGU9MQ==&t=1
- ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTM3Nzc3fENoaWxkSUQ9MjI2ODE2fFR5cGU9MQ==&t=1
- ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDk5NjQxfENoaWxkSUQ9NTM5NDU4fFR5cGU9MQ==&t=1
- ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MTM0MzEzfENoaWxkSUQ9LTF8VHlwZT0z&t=1
- ^ https://s21.q4cdn.com/104148044/files/doc_financials/quarterly_reports/2019/q3/Q32019-Earnings-Release.pdf
- ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results - BMS Newsroom". news.bms.com.
- ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results". investors.bms.com.
- ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2016 Financial Results - BMS Newsroom". news.bms.com.
- ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2015 Financial Results - BMS Newsroom". news.bms.com.
- ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2014 Financial Results - BMS Newsroom". news.bms.com.
- ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2013 Financial Results - BMS Newsroom". news.bms.com.
- ^ https://s21.q4cdn.com/104148044/files/doc_financials/annual_reports/Bristol-Myers-Squibb-2012AR-lr.pdf
- ^ https://s21.q4cdn.com/104148044/files/doc_financials/annual_reports/BristolMyersSquibb-2011-AnnualReport.pdf
- ^ https://www.biospace.com/article/releases/gilead-sciences-announces-third-quarter-2019-financial-results/?s=72
- ^ "Gilead Sciences Announces Fourth Quarter and Full Year 2018 Financial Results". BioSpace.
- ^ أ ب ت ث ج ح خ "Investor Overview". Gilead Sciences.
- ^ https://www.astrazeneca.com/content/dam/az/PDF/2019/q3/Year-to-date_and_Q3_2019_Results_announcement.pdf
- ^ https://www.astrazeneca.com/content/dam/az/PDF/2018/full-year/Full-Year_2018_Results_announcement.pdf
- ^ https://www.astrazeneca.com/content/dam/az/PDF/2017/Full-Year/Full-Year%202017%20Results%20announcement%20.pdf
- ^ https://www.astrazeneca.com/content/dam/az/PDF/Full_year_and_q4_2016_results/Full_Year_and_Q4_2016_Results_announcement.pdf
- ^ "Full-Year and Q4 2015 Results". www.astrazeneca.com.
- ^ "AstraZeneca PLC fourth quarter and full year results 2014". www.astrazeneca.com.
- ^ "AstraZeneca PLC fourth quarter and full year results 2013 - AstraZeneca". www.astrazeneca.com.
- ^ "AstraZeneca PLC Fourth quarter and full year results 2012". www.astrazeneca.com.
- ^ "AstraZeneca PLC Fourth quarter and full year results 2011". www.astrazeneca.com.
- ^ https://s22.q4cdn.com/366566841/files/doc_financials/2019/quarterly/Q1-2019-PR-tables.pdf
- ^ https://s24.q4cdn.com/720828402/files/doc_downloads/doc_financial/2018/q4/Teva-Form-10-K-2018.pdf
- ^ "Teva Reports 2017 Full Year and Fourth Quarter Financial Results".
- ^ http://www.tevapharm.com/news/teva_reports_full_year_and_fourth_quarter_2016_financial_results_02_17.aspx
- ^ http://www.tevapharm.com/news/teva_reports_full_year_2015_and_fourth_quarter_financial_results_02_16.aspx
- ^ "Teva Reports Fourth Quarter and Full Year 2014 Results". www.tevapharm.com.
- ^ http://www.tevapharm.com/news/teva_reports_fourth_quarter_and_full_year_2013_results_02_14.aspx
- ^ "Teva Reports Fourth Quarter and Full Year 2012 Results". tevapharm.com.
- ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MTI2NDkwfENoaWxkSUQ9LTF8VHlwZT0z&t=1
- ^ http://annualreport.boehringer-ingelheim.com/fileadmin/Download-Center/BI_GB_18_en_ohne_Unterschriften.pdf
- ^ "Boehringer Ingelheim 2017 Annual Report" (PDF). www.boehringer-ingelheim.com.
- ^ أ ب ت ث ج ح "Boehringer Ingelheim total revenue 2007-2017 - Statistic". Statista.
- ^ https://www.takeda.com/newsroom/newsreleases/2019/takeda-reports-fy2018-full-year-results-and-issues-fy2019-guidance/
- ^ "Takeda reports FY2017 full year results and issues FY2018 guidance". www.takeda.com.
- ^ https://www.merckgroup.com/content/dam/web/corporate/non-images/investors/reports-and-financials/earnings-materials/2019-q2/en/2019-Q2-Press-Release-EN.pdf
- ^ "Q4/FY Results of 2018 - News - Merck KGaA, Darmstadt, Germany". www.emdgroup.com.
- ^ أ ب ت ث "404 page - EMD Group". www.emdgroup.com.
{{cite web}}: Cite uses generic title (help) - ^ http://ar2016.merckgroup.com/sites/default/files/downloads/en/merck_annual_report_2016.pdf
- ^ http://ar2015.emdgroup.com/sites/default/files/downloads/emd/Merck_GB2015_EN.pdf
- ^ http://ar2014.merckgroup.com/sites/default/files/downloads/en/Merck_GB2014_EN.pdf
- ^ https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/quarterly_financial_reports/2019/20191101_Financial%20statement%20Q3%202019.pdf
- ^ https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/quarterly_financial_reports/2019/20190201_Financial%20statement%20Q4%202018_UK.pdf
- ^ "News details". www.novonordisk.com.
- ^ https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/quarterly_financial_reports/2017/20170202_Financial%20statement_FY%202016_UK.pdf
- ^ Transcripts, SA (3 February 2016). "Novo Nordisk's (NVO) CEO Lars Rebien Sorensen on Q4 2015 Results - Earnings Call Transcript".
- ^ Transcripts, SA (30 January 2015). "Novo Nordisk's (NVO) CEO Lars Sorensen on Q4 2014 Results - Earnings Call Transcript".
- ^ Transcripts, SA (31 January 2014). "Novo Nordisk A/S Management Discusses Q4 2013 Results - Earnings Call Transcript".
- ^ Transcripts, SA (31 January 2013). "Novo Nordisk's CEO Discusses Q4 2012 Results - Earnings Call Transcript".
- ^ http://www.novonordisk.co.uk/content/dam/Denmark/HQ/Commons/documents/Novo-Nordisk-AR-2011-en.pdf
- ^ https://www.allergan.com/investors/quarterly-results
- ^ "Allergan Reports Fourth Quarter and Full-Year 2018 Financial Results". BioSpace.
- ^ أ ب ت https://www.allergan.com/news/news/thomson-reuters/allergan-reports-solid-finish-to-2017
- ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTczMDc2fENoaWxkSUQ9Mjc1MzEzfFR5cGU9MQ==&t=1
- ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTM5MDk2fENoaWxkSUQ9MjI4NjI0fFR5cGU9MQ==&t=1
- ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MTc3MTM2fENoaWxkSUQ9LTF8VHlwZT0z&t=1
- ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDYwMzczfENoaWxkSUQ9NDg4Mzk1fFR5cGU9MQ==&t=1
- ^ https://www.biospace.com/article/releases/danaher-reports-third-quarter-2019-results/?s=72
- ^ http://investors.danaher.com/download/Danaher_Annual_Report_2018.pdf
- ^ http://investors.danaher.com/download/danaher_2017_annualreport.pdf
- ^ http://investors.danaher.com/download/Danaher_2016+Annual+Report.pdf
- ^ http://investors.danaher.com/download/2015+Danaher+Annual+Report.pdf
- ^ http://investors.danaher.com/download/DHR_AR_2014.pdf
- ^ http://investors.danaher.com/download/DHR_AR_2013.pdf
- ^ http://investors.danaher.com/download/DHR_AR_2012.pdf
- ^ http://investors.danaher.com/download/DHR_AR_2011.pdf
- ^ https://s22.q4cdn.com/728481125/files/doc_financials/2019/q3/2019-10-31-Q3-2019-earnings-deck_FINAL.pdf
- ^ "Celgene Reports Fourth Quarter and Full Year 2018 Operating and Financial Results". BioSpace.
- ^ https://investors.biogen.com/static-files/7863b554-d325-44e8-9c2d-ceace9698781
- ^ http://investors.biogen.com/static-files/c0d4fbe2-d4f2-404b-be17-19e770386d6e
- ^ "Biogen's Spinraza: Great Launch, Rough Ride". 25 January 2018 – via www.bloomberg.com.
- ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/Biogen_Annual_Report_2016_on_Form_10K.pdf
- ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/Biogen_Annual_Report_2015_on_Form_10K.pdf
- ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/Biogen_2014_Annual_Report_Web.pdf
- ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/BiogenIdec_AR_2013.pdf
- ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/BiogenIdec_AR_2012.pdf
- ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/2011ar.pdf
- ^ "Astellas Pharma Inc. Annual Report 2018" (PDF). www.astellas.com.
- ^ https://www.biospace.com/article/releases/labcorp-announces-2019-third-quarter-results-and-updates-2019-guidance/?s=72
- ^ أ ب ت ث ج http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDE2OTE0fENoaWxkSUQ9LTF8VHlwZT0z&t=1&cb=636873221632383468
- ^ أ ب ت http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MjI4ODI1fENoaWxkSUQ9LTF8VHlwZT0z&t=1
- ^ https://s22.q4cdn.com/911189824/files/doc_presentations/2019/10/Q3-2019-BAX-PRELIMINARY-RESULTS-FINANCIAL-SCHEDULES-(FINAL).pdf
- ^ أ ب https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2018/q4/Q4-2018-BAX-FINANCIAL-SCHEDULES-(FINAL).pdf
- ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2017/q4/Q4-2017-BAX-FINANCIAL-SCHEDULES-(FINAL).pdf
- ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2016/q4/Q4-2016-Financial-Schedules.pdf
- ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2015/q4/Q4-2015-Financial-Schedules.pdf
- ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2014/q4/Q4-2014-FINAL-Financial-Schedules.pdf
- ^ أ ب https://s22.q4cdn.com/911189824/files/doc_downloads/financial_schedules/2012/Reclassified-Sales-Final.pdf
- ^ https://www.biospace.com/article/releases/mylan-reports-second-quarter-2019-results/?s=72
- ^ أ ب ت ث ج http://investor.mylan.com/static-files/ed066de0-8491-4327-a044-9bb136d5b8c3
- ^ أ ب ت http://investor.mylan.com/static-files/29cc2678-5735-461a-9972-6ac01dfce6c4